With the deadline for phase 2 on the rapidly-approaching horizon, fresh challenges emerge for every organization along the pharmaceutical and biotech supply chain — not just manufacturers, but third-party logistics (3PL) providers, wholesalers, and dispensers, too.
How can companies ensure that they have the right supply chain solution to meet future track and trace compliance needs? Access this insightful white paper now to better understand the ‘what’ and ‘why’ of these changes, and ultimately how to ensure total supply chain compliancy.
What can be gained from this white paper
By submitting the form you agree to our Terms and Conditions
Who we are
Since 1997, ICS has partnered with pharmaceutical manufacturers to deliver customized healthcare logistics solutions that improve the quality and efficiency of their supply chains.
Tell me more